New drug combo aims to shrink tumors before cancer surgery
NCT ID NCT07400094
Summary
This study is testing a three-drug combination given before surgery to people with advanced but removable oral or larynx cancer. The goal is to see if this treatment can shrink or even eliminate the tumor before it is surgically removed, which may lead to better long-term results. After surgery, most patients will still need additional radiation or chemotherapy based on what is found, meaning this is a treatment to control the disease, not a one-time cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARYNGEAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
P.A. Hertsen Moscow Oncology Research Institute
Moscow, Russia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.